Table 5.
Comparison of cardiac function between the 2 groups.
| Group | Experimental group (n = 62) | Control group (n = 62) | T value | P value | |
|---|---|---|---|---|---|
| LVEF (%) | Pretreatment | 40.21 ± 2.13 | 41.51 ± 2.03 | -1.326 | .187 |
| 7 days after treatment | 51.36 ± 3.01* | 45.12 ± 2.95* | 7.362 | <.001 | |
| LVESD (mm) | Pretreatment | 46.98 ± 3.30 | 48.01 ± 3.03 | -1.460 | .146 |
| 7 days after treatment | 36.94 ± 2.22* | 41.56 ± 2.98* | -6.052 | <.001 | |
| LVEDD (mm) | Pretreatment | 63.32 ± 3.09 | 62.98 ± 4.04 | 0.395 | .693 |
| 7 days after treatment | 48.91 ± 2.13* | 55.21 ± 3.36* | -8.489 | <.001 |
LVEDD = left ventricular end-diastolic diameter, LVEF = left ventricular ejection fraction, LVESD = left ventricular end-systolic diameter.
*
There were significant differences in the group compared with before treatment (P < .05).